159 related articles for article (PubMed ID: 33251155)
1. Pre-Clinical Studies of Inactivated Polyvalent HFRS Vaccine.
Dzagurova TK; Siniugina AA; Ishmukhametov AA; Egorova MS; Kurashova SS; Balovneva MV; Deviatkin AA; Tkachenko PE; Leonovich OA; Tkachenko EA
Front Cell Infect Microbiol; 2020; 10():545372. PubMed ID: 33251155
[TBL] [Abstract][Full Text] [Related]
2. [Actual problems of hemorrhagic fever with renal syndrome].
Tkachenko EA; bernshtein AD; Dzagurova TK; Morozov VG; Slonova RA; Ivanov LI; Trankvilevskiĭ DV; Kruger D
Zh Mikrobiol Epidemiol Immunobiol; 2013; (1):51-8. PubMed ID: 23805652
[TBL] [Abstract][Full Text] [Related]
3. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
Hooper JW; Josleyn M; Ballantyne J; Brocato R
Vaccine; 2013 Sep; 31(40):4314-21. PubMed ID: 23892100
[TBL] [Abstract][Full Text] [Related]
4. [Passage adaptability of candidate strains for hemorrhagic fever with renal syndrome purified vaccine in Vero cells and their immunogenicity].
Chen W; Xue CF; Liu JQ; Li ZY; Fan YX; Xu L; Liao H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):129-32. PubMed ID: 12869992
[TBL] [Abstract][Full Text] [Related]
5. [Real-time PCR assay development for the control of vaccine against hemorrhagic fever with renal syndrome].
Egorova MS; Kurashova SS; Ishmukhametov AA; Balovneva MV; Deviatkin AA; Safonova MV; Ozherelkov SV; Khapchaev YK; Balkina AS; Belyakova AV; Dzagurova TK; Tkachenko EA
Vopr Virusol; 2021 Mar; 66(1):65-73. PubMed ID: 33683067
[TBL] [Abstract][Full Text] [Related]
6. A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus.
Chu YK; Jennings GB; Schmaljohn CS
J Virol; 1995 Oct; 69(10):6417-23. PubMed ID: 7666542
[TBL] [Abstract][Full Text] [Related]
7. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.
Hooper JW; Moon JE; Paolino KM; Newcomer R; McLain DE; Josleyn M; Hannaman D; Schmaljohn C
Clin Microbiol Infect; 2014 May; 20 Suppl 5():110-7. PubMed ID: 24447183
[TBL] [Abstract][Full Text] [Related]
8. [Discovery, clinical and etiological characteristic of hemorrhagic fever with renal syndrome in the subtropical zone of Krasnodar region].
Dzagurova TK; Tkachenko EA; Iunicheva IuV; Morozov VG; Briukhanov AF; Bashkirtsev VN; Sedova NS; Klempa B; Kruger D
Zh Mikrobiol Epidemiol Immunobiol; 2008; (1):12-6. PubMed ID: 18376466
[TBL] [Abstract][Full Text] [Related]
9. Cases of Hemorrhagic Fever with Renal Syndrome in Russia during 2000-2022.
Tkachenko E; Kurashova S; Balkina A; Ivanov A; Egorova M; Leonovich O; Popova Y; Teodorovich R; Belyakova A; Tkachenko P; Trankvilevsky D; Blinova E; Ishmukhametov A; Dzagurova T
Viruses; 2023 Jul; 15(7):. PubMed ID: 37515224
[TBL] [Abstract][Full Text] [Related]
10. [Development of ELISA on the basis of monoclonal antibodies for detecting specific activity of the vaccine against hemorrhagic fever with renal syndrome].
Dzagurova TK; Solopova ON; Sveshnikov PG; Korotina NA; Balovneva MV; Leonovich OA; Varlamov NE; Malkin GA; Sotskova SE; Tkachenko EA
Vopr Virusol; 2013; 58(1):40-4. PubMed ID: 23785761
[TBL] [Abstract][Full Text] [Related]
11. Pathogenicity of novel hantavirus isolate and antigenicity and immunogenicity of novel strain-based inactivated vaccine.
Liu YY; Xu YQ; Zhong Y; Wei F; Ling JX; Li JL; Yang L; Quan FY; Chen SL; Luo F; Hou W; Yang ZQ; Chen LJ; Xiong HR
Vaccine; 2023 Nov; 41(49):7482-7490. PubMed ID: 37953099
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.
Hooper JW; Custer DM; Thompson E; Schmaljohn CS
J Virol; 2001 Sep; 75(18):8469-77. PubMed ID: 11507192
[TBL] [Abstract][Full Text] [Related]
13. Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells.
Choi Y; Ahn CJ; Seong KM; Jung MY; Ahn BY
Vaccine; 2003 May; 21(17-18):1867-73. PubMed ID: 12706671
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine.
Yoo YC; Yoshimatsu K; Koike Y; Hatsuse R; Yamanishi K; Tanishita O; Arikawa J; Azuma I
Vaccine; 1998; 16(2-3):216-24. PubMed ID: 9607033
[TBL] [Abstract][Full Text] [Related]
15. Hantaan and Puumala virus antibodies in blood donors in Samara, an HFRS-endemic region in European Russia.
Alexeyev OA; Elgh F; Zhestkov AV; Wadell G; Juto P
Lancet; 1996 May; 347(9013):1483. PubMed ID: 8676649
[No Abstract] [Full Text] [Related]
16. Investigation of a subunit protein vaccine for HFRS based on a consensus sequence between envelope glycoproteins of HTNV and SEOV.
Liu R; Lv Y; Sun W; Li M; Ge N; Zhu C; Ding Y; Liu Z; Ma R; Huang Y; Hou S; Ying Q; Gu T; Wang F; Nie L; Wang Y; Huang W; Shu J; Wu X
Virus Res; 2023 Sep; 334():199149. PubMed ID: 37329903
[TBL] [Abstract][Full Text] [Related]
17. Detection of Hantaan and Seoul viruses by reverse transcriptase-polymerase chain reaction (RT-PCR) and restriction fragment length polymorphism (RFLP) in renal syndrome patients with hemorrhagic fever.
Ahn C; Cho JT; Lee JG; Lim CS; Kim YY; Han JS; Kim S; Lee JS
Clin Nephrol; 2000 Feb; 53(2):79-89. PubMed ID: 10711409
[TBL] [Abstract][Full Text] [Related]
18. Genetic diversity of hantaviruses associated with hemorrhagic fever with renal syndrome in the far east of Russia.
Yashina LN; Patrushev NA; Ivanov LI; Slonova RA; Mishin VP; Kompanez GG; Zdanovskaya NI; Kuzina II; Safronov PF; Chizhikov VE; Schmaljohn C; Netesov SV
Virus Res; 2000 Sep; 70(1-2):31-44. PubMed ID: 11074123
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant neutralizing antibodies against hantaan virus G2 protein.
Koch J; Liang M; Queitsch I; Kraus AA; Bautz EK
Virology; 2003 Mar; 308(1):64-73. PubMed ID: 12706090
[TBL] [Abstract][Full Text] [Related]
20. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome.
Boudreau EF; Josleyn M; Ullman D; Fisher D; Dalrymple L; Sellers-Myers K; Loudon P; Rusnak J; Rivard R; Schmaljohn C; Hooper JW
Vaccine; 2012 Mar; 30(11):1951-8. PubMed ID: 22248821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
